Medicinal products for paediatric use

This procedure concerns the development and authorisation of medicines specifically for children. It aims to ensure that paediatric medicines are safe and effective, addressing a gap in current pharmaceutical development which often overlooks the specific needs of younger populations.

It affects children, healthcare professionals, and the pharmaceutical industry. The goal is to improve treatment outcomes for paediatric patients and encourage innovation in paediatric medicine.